GlassScriptPhysician profile
Lyle Don Workman
NPI 1346511714
$1,956.10
in general payments reported to CMS, 2019-2025
20 companies · $440 in 2025
The $440 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $176 · 2021: $332 · 2022: $282 · 2023: $223 · 2024: $390 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $636.50 | 2019-2025 | Dyanavel Xr |
| Cranial Technologies, INC | $180.98 | 2019-2025 | Doc Band |
| Pfizer INC. | $161.52 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $145.49 | 2022-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $131.81 | 2024-2025 | |
| Sanofi Pasteur INC. | $102.15 | 2021-2025 | |
| Adlon Therapeutics L.P. | $93.40 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $86.37 | 2019-2025 | Kristalose |
| Sobi, INC | $69.42 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.64 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $47.29 | 2023 | |
| Ironshore Pharmaceuticals INC. | $43.17 | 2020-2024 | |
| Alk-Abello, INC | $39.92 | 2025 | Neffy |
| Seqirus USA INC | $35.21 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Corium, LLC | $34.23 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $34.15 | 2025 | Zelsuvmi |
| Cipher Pharmaceuticals US LLC | $24.35 | 2025 | Natroba, Spinosad |
| Aytu Biopharma, INC. | $15.12 | 2021 | |
| Phadia US INC. | $13.18 | 2022 | |
| Shire North American Group INC | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyle Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.